Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Bloom has pioneered a technology to transform plant waste into valuable chemical products
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Zydus will carry out early-stage development, animal immunogenicity studies and regulatory preclinical toxicology studies for this combination vaccine
Subscribe To Our Newsletter & Stay Updated